Lipopolysaccharide inhibits macrophage phagocytosis of apoptotic neutrophils by regulating the production of tumour necrosis factor α and growth arrest-specific gene 6

被引:74
作者
Feng, Xueying [1 ]
Deng, Tingting [1 ]
Zhang, Yue [1 ]
Su, Shaobo [2 ]
Wei, Chiju [3 ]
Han, Daishu [1 ]
机构
[1] Peking Union Med Coll, Dept Cell Biol, Sch Basic Med, Beijing 100005, Peoples R China
[2] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China
[3] Shantou Univ, Multidisciplinary Res Ctr, Shantou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
inflammation; lipopolysaccharide; macrophage; phagocytosis; PROGRAMMED CELL-DEATH; INFLAMMATORY MEDIATORS; TAM RECEPTORS; TNF-ALPHA; IN-VITRO; CLEARANCE; RESOLUTION; DISEASE; KINASE; GAS6;
D O I
10.1111/j.1365-2567.2010.03364.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>Removal of apoptotic cells from inflammatory sites by macrophages is an important step in the resolution of inflammation. However, the effect of inflammatory modulators on phagocytic clearance of apoptotic cells remains to be clarified. In this paper, we demonstrate that lipopolysaccharide (LPS), a potent inflammatory agent, inhibits the phagocytosis of apoptotic neutrophils by mouse peritoneal macrophages. This inhibition can be attributed to both LPS-mediated induction of tumour necrosis factor (TNF-alpha) and suppression of growth arrest-specific gene 6 (Gas6) in macrophages. We found that LPS-induced TNF-alpha production inhibited phagocytic ability of macrophages in an autocrine manner. In contrast, Gas6 expression in macrophages was blocked by LPS, which also contributes to the inhibition of macrophage phagocytosis by LPS. Our data suggest that phagocytic clearance of apoptotic neutrophils by macrophages can be regulated by local pro- and anti-inflammatory factors in two opposite states.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 32 条
[1]  
Angelillo Scherrer A, 2008, J CLIN INVEST, V118, P583
[2]  
Bellido Martin L, 2008, VITAM HORM, V78, P185
[3]   Regulation of cytokine production during phagocytosis of apoptotic cells [J].
Chung, EY ;
Kim, SJ ;
Ma, XJ .
CELL RESEARCH, 2006, 16 (02) :154-161
[4]   How TNF was recognized as a key mechanism of disease [J].
Clark, Ian A. .
CYTOKINE & GROWTH FACTOR REVIEWS, 2007, 18 (3-4) :335-343
[5]   The final step in programmed cell death: phagocytes carry apoptotic cells to the grave [J].
deCathelineau, AM ;
Henson, PM .
PROGRAMMED CELL DEATH, 2003, 39 :105-117
[6]   A receptor for phosphatidylserine-specific clearance of apoptotic cells [J].
Fadok, VA ;
Bratton, DL ;
Rose, DM ;
Pearson, A ;
Ezekewitz, RAB ;
Henson, PM .
NATURE, 2000, 405 (6782) :85-90
[7]   TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases [J].
Feldmann, M ;
Maini, RN .
NATURE MEDICINE, 2003, 9 (10) :1245-1250
[8]   Inflammatory resolution: New opportunities for drug discovery [J].
Gilroy, DW ;
Lawrence, T ;
Perretti, M ;
Rossi, AG .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) :401-416
[9]   Phagocytosis and innate immunity [J].
Greenberg, S ;
Grinstein, S .
CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (01) :136-145
[10]   Gas6 and protein S [J].
Hafizi, Sassan ;
Dahlback, Bjorn .
FEBS JOURNAL, 2006, 273 (23) :5231-5244